Alerts will be sent to your verified email
Verify Email
POSITRON
|
Positron Energy
|
Balaxi Pharma.
|
WH Brady
|
|
|---|---|---|---|
|
Operational Metrics
|
|||
|
Financials
|
|||
|
5 yr Average ROE
|
28.49 % | 27.3 % | 14.06 % |
|
5yr average Equity Multiplier
|
2.58 | 1.4 | 1.63 |
|
5yr Average Asset Turnover Ratio
|
2.01 | 1.43 | 0.84 |
|
5yr Avg Net Profit Margin
|
5.86 % | 11.03 % | 10.43 % |
|
Price to Book
|
2.01 | 0.67 | 1.88 |
|
P/E
|
8.89 | 10.97 | 9.16 |
|
5yr Avg Cash Conversion Cycle
|
12.01 Days | 154.28 Days | 71.04 Days |
|
Inventory Days
|
14.67 Days | 87.41 Days | 60.91 Days |
|
Days Receivable
|
25.28 Days | 103.86 Days | 78.47 Days |
|
Days Payable
|
26.53 Days | 63.18 Days | 69.16 Days |
|
5yr Average Interest Coverage Ratio
|
12.35 | 57.05 | 13.55 |
|
5yr Avg ROCE
|
25.69 % | 36.52 % | 15.82 % |
|
5yr Avg Operating Profit Margin
|
7.82 % | 16.64 % | 12.7 % |
|
5 yr average Debt to Equity
|
0.7 | 0.09 | 0.11 |
|
5yr CAGR Net Profit
|
138.58 % | -5.76 % | 36.84 % |
|
5yr Average Return on Assets
|
11.43 % | 18.47 % | 8.61 % |
|
Shareholdings
|
|||
|
Promoter Holding
|
72.04 % | 65.99 % | 73.76 % |
|
Share Pledged by Promoters
|
0.0 | 0.0 | 0.0 |
|
Change in Promoter Holding (3 Yrs)
|
0.04 % | -6.87 % | 0.0 |
|
Change in Mutual Fund Holding (3 Yrs)
|
0.0 | 0.0 | 0.0 |
|
Positron Energy
|
Balaxi Pharma.
|
WH Brady
|
|
|---|---|---|---|
|
Product Wise Break-Up
|
Product Wise Break-Up
|
Product Wise Break-Up
|
Product Wise Break-Up
|